α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study

DOI: 10.1186/s12933-017-0571-1

Keywords: Acute coronary syndrome, Glucose fluctuation, Heart rate variability, Hypoglycemia, Miglitol, Sympathetic nervous system activity, Type 2 diabetes

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (doi:10.1186/s12933-017-0571-1) contains supplementary material, which is available to authorized users

Full-Text